~~<i id='6EF611C9D0'><strike id='6EF611C9D0'><tt id='6EF611C9D0'><pre id='6EF611C9D0'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

fashion

author：focus 2025-09-29 01:38:58 - browse：8

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

A couple billion here, a couple billion there, and pretty soon Eli Lilly hopes it will be talking about real money.

Eli Lilly agreed to purchase Point Biopharma Tuesday morning for $1.4 billion, a 90% premium, adding to its pipeline of cancer drugs. Point is developing cancer drugs that deliver a focused dose of radiation to tumor cells. Data for its lead medicine, for prostate cancer, are expected in the fourth quarter. It is also developing a drug for neuroendocrine tumors.

Point operates a 180,000-square-foot radiopharmaceutical manufacturing facility in Indianapolis, and a radiopharmaceutical research and development center in Toronto.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

Wikipedia

hotspot

entertainment

hotspot

Wikipedia

knowledge

R.ShawnMartin,theCEOoftheAmericanAcademyofFamilyPhysiciansCourtesyAmericanAcademyofFamilyPhysiciansI

WSS

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Why health care costs have stayed mostly flat since 2010

Eyeing GLP

Fentanyl is making it harder to start addiction treatment

Medicare Advantage beneficiaries sue Humana over algorithm use

Medicare Advantage beneficiaries sue Humana over algorithm use

explore

fashion

Wikipedia

DIEP, the 'gold standard' of breast reconstruction, is under threat

CRISPR gene editing developments we’re watching in 2024

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Liver decline slowed by off

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Heart attack and stroke risk calculators need revising

UnitedHealth argues against case alleging wrongful AI care denials

State Dept. review finds Biden bears some blame for Afghanistan failures

Bristol Myers buys into radiopharmaceuticals with RayzeBio

hotspot

Bird flu surveillance in wastewater gets boost from consortium

Hospitals owned by private equity see complications spike 25%

Readout Newsletter: The latest on Moderna, Apellis, and Merck

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Reports of telehealth's death have been greatly exaggerated

entertainment

hotspot

Wikipedia

knowledge